nodes	percent_of_prediction	percent_of_DWPC	metapath
Galantamine—CHRNA5—lung cancer	0.26	0.466	CbGaD
Galantamine—CHRNB4—lung cancer	0.176	0.315	CbGaD
Galantamine—CHRNA3—lung cancer	0.122	0.218	CbGaD
Galantamine—ACHE—Irinotecan—lung cancer	0.0377	0.235	CbGbCtD
Galantamine—BCHE—Irinotecan—lung cancer	0.0227	0.141	CbGbCtD
Galantamine—BCHE—Cisplatin—lung cancer	0.0185	0.115	CbGbCtD
Galantamine—CYP2D6—Gefitinib—lung cancer	0.0102	0.0634	CbGbCtD
Galantamine—CYP2D6—Vinorelbine—lung cancer	0.00784	0.0488	CbGbCtD
Galantamine—CHRND—pericardium—lung cancer	0.00714	0.247	CbGeAlD
Galantamine—CYP3A4—Topotecan—lung cancer	0.00707	0.0441	CbGbCtD
Galantamine—CYP3A4—Gefitinib—lung cancer	0.00647	0.0403	CbGbCtD
Galantamine—CYP3A4—Teniposide—lung cancer	0.00627	0.0391	CbGbCtD
Galantamine—CYP2D6—Erlotinib—lung cancer	0.00602	0.0375	CbGbCtD
Galantamine—CYP3A4—Vinorelbine—lung cancer	0.00498	0.031	CbGbCtD
Galantamine—CYP2D6—Vinblastine—lung cancer	0.00483	0.0301	CbGbCtD
Galantamine—CYP3A4—Crizotinib—lung cancer	0.00397	0.0247	CbGbCtD
Galantamine—CYP3A4—Erlotinib—lung cancer	0.00383	0.0238	CbGbCtD
Galantamine—CYP3A4—Paclitaxel—lung cancer	0.0035	0.0218	CbGbCtD
Galantamine—CYP3A4—Irinotecan—lung cancer	0.00346	0.0215	CbGbCtD
Galantamine—BCHE—diaphragm—lung cancer	0.00327	0.113	CbGeAlD
Galantamine—CYP3A4—Vinblastine—lung cancer	0.00307	0.0191	CbGbCtD
Galantamine—CYP2D6—Doxorubicin—lung cancer	0.00297	0.0185	CbGbCtD
Galantamine—CYP3A4—Etoposide—lung cancer	0.00277	0.0172	CbGbCtD
Galantamine—CYP3A4—Docetaxel—lung cancer	0.00253	0.0158	CbGbCtD
Galantamine—CYP3A4—Doxorubicin—lung cancer	0.00189	0.0118	CbGbCtD
Galantamine—CHRNA2—mammary gland—lung cancer	0.00141	0.0489	CbGeAlD
Galantamine—CHRND—respiratory system—lung cancer	0.00136	0.047	CbGeAlD
Galantamine—CHRNG—trachea—lung cancer	0.00127	0.0438	CbGeAlD
Galantamine—CHRNA3—respiratory system—lung cancer	0.00101	0.035	CbGeAlD
Galantamine—CHRNG—bone marrow—lung cancer	0.001	0.0348	CbGeAlD
Galantamine—CHRNG—lung—lung cancer	0.00091	0.0315	CbGeAlD
Galantamine—CHRNA5—lymph node—lung cancer	0.000871	0.0301	CbGeAlD
Galantamine—CHRNB2—bronchus—lung cancer	0.00086	0.0297	CbGeAlD
Galantamine—CHRFAM7A—respiratory system—lung cancer	0.000819	0.0283	CbGeAlD
Galantamine—CHRNB2—trachea—lung cancer	0.000772	0.0267	CbGeAlD
Galantamine—CHRND—lung—lung cancer	0.000722	0.025	CbGeAlD
Galantamine—CHRNA4—respiratory system—lung cancer	0.000653	0.0226	CbGeAlD
Galantamine—CHRNB2—bone marrow—lung cancer	0.000612	0.0212	CbGeAlD
Galantamine—CHRFAM7A—trachea—lung cancer	0.000605	0.0209	CbGeAlD
Galantamine—CHRNB2—lung—lung cancer	0.000555	0.0192	CbGeAlD
Galantamine—CHRNA3—lung—lung cancer	0.000538	0.0186	CbGeAlD
Galantamine—CHRNA4—bronchus—lung cancer	0.000537	0.0186	CbGeAlD
Galantamine—CHRNA10—lymph node—lung cancer	0.000528	0.0183	CbGeAlD
Galantamine—CHRNB2—lymph node—lung cancer	0.000379	0.0131	CbGeAlD
Galantamine—BCHE—respiratory system—lung cancer	0.000373	0.0129	CbGeAlD
Galantamine—CHRNA3—lymph node—lung cancer	0.000368	0.0127	CbGeAlD
Galantamine—CHRNA4—lung—lung cancer	0.000347	0.012	CbGeAlD
Galantamine—Morphine—UGT1A1—lung cancer	0.000335	0.81	CrCbGaD
Galantamine—CHRNB1—lymph node—lung cancer	0.000318	0.011	CbGeAlD
Galantamine—BCHE—bronchus—lung cancer	0.000307	0.0106	CbGeAlD
Galantamine—BCHE—trachea—lung cancer	0.000276	0.00955	CbGeAlD
Galantamine—ACHE—lymph node—lung cancer	0.000276	0.00955	CbGeAlD
Galantamine—BCHE—cardiac atrium—lung cancer	0.000259	0.00897	CbGeAlD
Galantamine—BCHE—bone marrow—lung cancer	0.000219	0.00757	CbGeAlD
Galantamine—BCHE—lung—lung cancer	0.000198	0.00686	CbGeAlD
Galantamine—BCHE—lymph node—lung cancer	0.000136	0.00469	CbGeAlD
Galantamine—Morphine—ABCB1—lung cancer	7.84e-05	0.19	CrCbGaD
Galantamine—Paraesthesia—Etoposide—lung cancer	5.41e-05	0.0005	CcSEcCtD
Galantamine—Haematuria—Methotrexate—lung cancer	5.39e-05	0.000498	CcSEcCtD
Galantamine—Loss of consciousness—Docetaxel—lung cancer	5.39e-05	0.000498	CcSEcCtD
Galantamine—Musculoskeletal discomfort—Paclitaxel—lung cancer	5.38e-05	0.000497	CcSEcCtD
Galantamine—Somnolence—Etoposide—lung cancer	5.35e-05	0.000495	CcSEcCtD
Galantamine—Cough—Docetaxel—lung cancer	5.35e-05	0.000494	CcSEcCtD
Galantamine—Hepatobiliary disease—Methotrexate—lung cancer	5.35e-05	0.000494	CcSEcCtD
Galantamine—Insomnia—Paclitaxel—lung cancer	5.34e-05	0.000493	CcSEcCtD
Galantamine—Epistaxis—Methotrexate—lung cancer	5.33e-05	0.000493	CcSEcCtD
Galantamine—Hypersensitivity—Irinotecan—lung cancer	5.33e-05	0.000493	CcSEcCtD
Galantamine—Convulsion—Docetaxel—lung cancer	5.31e-05	0.000491	CcSEcCtD
Galantamine—Paraesthesia—Paclitaxel—lung cancer	5.3e-05	0.00049	CcSEcCtD
Galantamine—Hypertension—Docetaxel—lung cancer	5.29e-05	0.000489	CcSEcCtD
Galantamine—Bronchitis—Doxorubicin—lung cancer	5.28e-05	0.000488	CcSEcCtD
Galantamine—Somnolence—Paclitaxel—lung cancer	5.25e-05	0.000485	CcSEcCtD
Galantamine—Decreased appetite—Etoposide—lung cancer	5.24e-05	0.000484	CcSEcCtD
Galantamine—Chest pain—Docetaxel—lung cancer	5.22e-05	0.000482	CcSEcCtD
Galantamine—Arthralgia—Docetaxel—lung cancer	5.22e-05	0.000482	CcSEcCtD
Galantamine—Myalgia—Docetaxel—lung cancer	5.22e-05	0.000482	CcSEcCtD
Galantamine—Nausea—Vinorelbine—lung cancer	5.21e-05	0.000482	CcSEcCtD
Galantamine—Gastrointestinal disorder—Etoposide—lung cancer	5.2e-05	0.00048	CcSEcCtD
Galantamine—Dyspepsia—Paclitaxel—lung cancer	5.2e-05	0.00048	CcSEcCtD
Galantamine—Body temperature increased—Cisplatin—lung cancer	5.2e-05	0.00048	CcSEcCtD
Galantamine—Asthenia—Irinotecan—lung cancer	5.19e-05	0.00048	CcSEcCtD
Galantamine—Fatigue—Etoposide—lung cancer	5.19e-05	0.00048	CcSEcCtD
Galantamine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	5.19e-05	0.000479	CcSEcCtD
Galantamine—Constipation—Etoposide—lung cancer	5.15e-05	0.000476	CcSEcCtD
Galantamine—Decreased appetite—Paclitaxel—lung cancer	5.13e-05	0.000474	CcSEcCtD
Galantamine—Dry mouth—Docetaxel—lung cancer	5.11e-05	0.000472	CcSEcCtD
Galantamine—Upper respiratory tract infection—Doxorubicin—lung cancer	5.11e-05	0.000472	CcSEcCtD
Galantamine—Haemoglobin—Methotrexate—lung cancer	5.1e-05	0.000471	CcSEcCtD
Galantamine—Gastrointestinal disorder—Paclitaxel—lung cancer	5.1e-05	0.000471	CcSEcCtD
Galantamine—Fatigue—Paclitaxel—lung cancer	5.09e-05	0.00047	CcSEcCtD
Galantamine—Haemorrhage—Methotrexate—lung cancer	5.08e-05	0.000469	CcSEcCtD
Galantamine—Hepatitis—Methotrexate—lung cancer	5.08e-05	0.000469	CcSEcCtD
Galantamine—Pollakiuria—Doxorubicin—lung cancer	5.07e-05	0.000469	CcSEcCtD
Galantamine—Asthenia—Gemcitabine—lung cancer	5.06e-05	0.000467	CcSEcCtD
Galantamine—Constipation—Paclitaxel—lung cancer	5.05e-05	0.000466	CcSEcCtD
Galantamine—Confusional state—Docetaxel—lung cancer	5.05e-05	0.000466	CcSEcCtD
Galantamine—Urinary tract disorder—Methotrexate—lung cancer	5.01e-05	0.000463	CcSEcCtD
Galantamine—Urethral disorder—Methotrexate—lung cancer	4.98e-05	0.00046	CcSEcCtD
Galantamine—Weight decreased—Doxorubicin—lung cancer	4.97e-05	0.000459	CcSEcCtD
Galantamine—Feeling abnormal—Etoposide—lung cancer	4.96e-05	0.000458	CcSEcCtD
Galantamine—Hyperglycaemia—Doxorubicin—lung cancer	4.95e-05	0.000458	CcSEcCtD
Galantamine—Diarrhoea—Irinotecan—lung cancer	4.95e-05	0.000458	CcSEcCtD
Galantamine—Pneumonia—Doxorubicin—lung cancer	4.93e-05	0.000455	CcSEcCtD
Galantamine—Gastrointestinal pain—Etoposide—lung cancer	4.92e-05	0.000455	CcSEcCtD
Galantamine—Shock—Docetaxel—lung cancer	4.92e-05	0.000455	CcSEcCtD
Galantamine—Nervous system disorder—Docetaxel—lung cancer	4.91e-05	0.000453	CcSEcCtD
Galantamine—Thrombocytopenia—Docetaxel—lung cancer	4.9e-05	0.000453	CcSEcCtD
Galantamine—Visual impairment—Methotrexate—lung cancer	4.89e-05	0.000452	CcSEcCtD
Galantamine—Tachycardia—Docetaxel—lung cancer	4.88e-05	0.000451	CcSEcCtD
Galantamine—Feeling abnormal—Paclitaxel—lung cancer	4.87e-05	0.00045	CcSEcCtD
Galantamine—Skin disorder—Docetaxel—lung cancer	4.86e-05	0.000449	CcSEcCtD
Galantamine—Hypersensitivity—Cisplatin—lung cancer	4.84e-05	0.000447	CcSEcCtD
Galantamine—Gastrointestinal pain—Paclitaxel—lung cancer	4.83e-05	0.000446	CcSEcCtD
Galantamine—Diarrhoea—Gemcitabine—lung cancer	4.83e-05	0.000446	CcSEcCtD
Galantamine—Renal failure—Doxorubicin—lung cancer	4.81e-05	0.000445	CcSEcCtD
Galantamine—Neuropathy peripheral—Doxorubicin—lung cancer	4.8e-05	0.000444	CcSEcCtD
Galantamine—Dizziness—Irinotecan—lung cancer	4.79e-05	0.000442	CcSEcCtD
Galantamine—Anorexia—Docetaxel—lung cancer	4.77e-05	0.000441	CcSEcCtD
Galantamine—Body temperature increased—Etoposide—lung cancer	4.76e-05	0.00044	CcSEcCtD
Galantamine—Abdominal pain—Etoposide—lung cancer	4.76e-05	0.00044	CcSEcCtD
Galantamine—Urinary tract infection—Doxorubicin—lung cancer	4.76e-05	0.00044	CcSEcCtD
Galantamine—Eye disorder—Methotrexate—lung cancer	4.75e-05	0.000438	CcSEcCtD
Galantamine—Tinnitus—Methotrexate—lung cancer	4.73e-05	0.000437	CcSEcCtD
Galantamine—Asthenia—Cisplatin—lung cancer	4.72e-05	0.000436	CcSEcCtD
Galantamine—Cardiac disorder—Methotrexate—lung cancer	4.71e-05	0.000435	CcSEcCtD
Galantamine—Hypotension—Docetaxel—lung cancer	4.68e-05	0.000432	CcSEcCtD
Galantamine—Haematuria—Doxorubicin—lung cancer	4.67e-05	0.000431	CcSEcCtD
Galantamine—Body temperature increased—Paclitaxel—lung cancer	4.67e-05	0.000431	CcSEcCtD
Galantamine—Abdominal pain—Paclitaxel—lung cancer	4.67e-05	0.000431	CcSEcCtD
Galantamine—Hepatobiliary disease—Doxorubicin—lung cancer	4.63e-05	0.000428	CcSEcCtD
Galantamine—Epistaxis—Doxorubicin—lung cancer	4.62e-05	0.000427	CcSEcCtD
Galantamine—Angiopathy—Methotrexate—lung cancer	4.61e-05	0.000426	CcSEcCtD
Galantamine—Vomiting—Irinotecan—lung cancer	4.6e-05	0.000425	CcSEcCtD
Galantamine—Immune system disorder—Methotrexate—lung cancer	4.59e-05	0.000424	CcSEcCtD
Galantamine—Rash—Irinotecan—lung cancer	4.57e-05	0.000422	CcSEcCtD
Galantamine—Dermatitis—Irinotecan—lung cancer	4.56e-05	0.000421	CcSEcCtD
Galantamine—Musculoskeletal discomfort—Docetaxel—lung cancer	4.56e-05	0.000421	CcSEcCtD
Galantamine—Headache—Irinotecan—lung cancer	4.54e-05	0.000419	CcSEcCtD
Galantamine—Insomnia—Docetaxel—lung cancer	4.53e-05	0.000418	CcSEcCtD
Galantamine—Diarrhoea—Cisplatin—lung cancer	4.5e-05	0.000416	CcSEcCtD
Galantamine—Paraesthesia—Docetaxel—lung cancer	4.49e-05	0.000415	CcSEcCtD
Galantamine—Vomiting—Gemcitabine—lung cancer	4.48e-05	0.000414	CcSEcCtD
Galantamine—Bradycardia—Doxorubicin—lung cancer	4.48e-05	0.000413	CcSEcCtD
Galantamine—Somnolence—Docetaxel—lung cancer	4.45e-05	0.000411	CcSEcCtD
Galantamine—Mental disorder—Methotrexate—lung cancer	4.45e-05	0.000411	CcSEcCtD
Galantamine—Rash—Gemcitabine—lung cancer	4.45e-05	0.000411	CcSEcCtD
Galantamine—Dermatitis—Gemcitabine—lung cancer	4.44e-05	0.00041	CcSEcCtD
Galantamine—Hypersensitivity—Etoposide—lung cancer	4.44e-05	0.00041	CcSEcCtD
Galantamine—Malnutrition—Methotrexate—lung cancer	4.42e-05	0.000408	CcSEcCtD
Galantamine—Haemoglobin—Doxorubicin—lung cancer	4.42e-05	0.000408	CcSEcCtD
Galantamine—Headache—Gemcitabine—lung cancer	4.42e-05	0.000408	CcSEcCtD
Galantamine—Rhinitis—Doxorubicin—lung cancer	4.41e-05	0.000407	CcSEcCtD
Galantamine—Dyspepsia—Docetaxel—lung cancer	4.41e-05	0.000407	CcSEcCtD
Galantamine—Haemorrhage—Doxorubicin—lung cancer	4.4e-05	0.000406	CcSEcCtD
Galantamine—Hepatitis—Doxorubicin—lung cancer	4.4e-05	0.000406	CcSEcCtD
Galantamine—Decreased appetite—Docetaxel—lung cancer	4.35e-05	0.000402	CcSEcCtD
Galantamine—Hypersensitivity—Paclitaxel—lung cancer	4.35e-05	0.000402	CcSEcCtD
Galantamine—Urinary tract disorder—Doxorubicin—lung cancer	4.34e-05	0.000401	CcSEcCtD
Galantamine—Oedema peripheral—Doxorubicin—lung cancer	4.33e-05	0.0004	CcSEcCtD
Galantamine—Dysgeusia—Methotrexate—lung cancer	4.33e-05	0.0004	CcSEcCtD
Galantamine—Gastrointestinal disorder—Docetaxel—lung cancer	4.32e-05	0.000399	CcSEcCtD
Galantamine—Asthenia—Etoposide—lung cancer	4.32e-05	0.000399	CcSEcCtD
Galantamine—Connective tissue disorder—Doxorubicin—lung cancer	4.32e-05	0.000399	CcSEcCtD
Galantamine—Fatigue—Docetaxel—lung cancer	4.32e-05	0.000399	CcSEcCtD
Galantamine—Urethral disorder—Doxorubicin—lung cancer	4.31e-05	0.000398	CcSEcCtD
Galantamine—Nausea—Irinotecan—lung cancer	4.3e-05	0.000397	CcSEcCtD
Galantamine—Constipation—Docetaxel—lung cancer	4.28e-05	0.000395	CcSEcCtD
Galantamine—Back pain—Methotrexate—lung cancer	4.28e-05	0.000395	CcSEcCtD
Galantamine—Visual impairment—Doxorubicin—lung cancer	4.24e-05	0.000391	CcSEcCtD
Galantamine—Asthenia—Paclitaxel—lung cancer	4.24e-05	0.000391	CcSEcCtD
Galantamine—Nausea—Gemcitabine—lung cancer	4.19e-05	0.000387	CcSEcCtD
Galantamine—Vomiting—Cisplatin—lung cancer	4.18e-05	0.000386	CcSEcCtD
Galantamine—Vision blurred—Methotrexate—lung cancer	4.17e-05	0.000385	CcSEcCtD
Galantamine—Rash—Cisplatin—lung cancer	4.14e-05	0.000383	CcSEcCtD
Galantamine—Dermatitis—Cisplatin—lung cancer	4.14e-05	0.000383	CcSEcCtD
Galantamine—Feeling abnormal—Docetaxel—lung cancer	4.12e-05	0.000381	CcSEcCtD
Galantamine—Diarrhoea—Etoposide—lung cancer	4.12e-05	0.000381	CcSEcCtD
Galantamine—Eye disorder—Doxorubicin—lung cancer	4.11e-05	0.00038	CcSEcCtD
Galantamine—Ill-defined disorder—Methotrexate—lung cancer	4.1e-05	0.000379	CcSEcCtD
Galantamine—Tinnitus—Doxorubicin—lung cancer	4.1e-05	0.000379	CcSEcCtD
Galantamine—Gastrointestinal pain—Docetaxel—lung cancer	4.09e-05	0.000378	CcSEcCtD
Galantamine—Anaemia—Methotrexate—lung cancer	4.09e-05	0.000377	CcSEcCtD
Galantamine—Cardiac disorder—Doxorubicin—lung cancer	4.08e-05	0.000377	CcSEcCtD
Galantamine—Flushing—Doxorubicin—lung cancer	4.08e-05	0.000377	CcSEcCtD
Galantamine—Diarrhoea—Paclitaxel—lung cancer	4.04e-05	0.000373	CcSEcCtD
Galantamine—Angiopathy—Doxorubicin—lung cancer	3.99e-05	0.000369	CcSEcCtD
Galantamine—Malaise—Methotrexate—lung cancer	3.99e-05	0.000368	CcSEcCtD
Galantamine—Dizziness—Etoposide—lung cancer	3.98e-05	0.000368	CcSEcCtD
Galantamine—Immune system disorder—Doxorubicin—lung cancer	3.97e-05	0.000367	CcSEcCtD
Galantamine—Vertigo—Methotrexate—lung cancer	3.97e-05	0.000367	CcSEcCtD
Galantamine—Body temperature increased—Docetaxel—lung cancer	3.96e-05	0.000366	CcSEcCtD
Galantamine—Abdominal pain—Docetaxel—lung cancer	3.96e-05	0.000366	CcSEcCtD
Galantamine—Arrhythmia—Doxorubicin—lung cancer	3.93e-05	0.000363	CcSEcCtD
Galantamine—Dizziness—Paclitaxel—lung cancer	3.9e-05	0.000361	CcSEcCtD
Galantamine—Nausea—Cisplatin—lung cancer	3.9e-05	0.000361	CcSEcCtD
Galantamine—Cough—Methotrexate—lung cancer	3.86e-05	0.000356	CcSEcCtD
Galantamine—Mental disorder—Doxorubicin—lung cancer	3.85e-05	0.000356	CcSEcCtD
Galantamine—Convulsion—Methotrexate—lung cancer	3.83e-05	0.000354	CcSEcCtD
Galantamine—Vomiting—Etoposide—lung cancer	3.83e-05	0.000354	CcSEcCtD
Galantamine—Malnutrition—Doxorubicin—lung cancer	3.83e-05	0.000354	CcSEcCtD
Galantamine—Rash—Etoposide—lung cancer	3.8e-05	0.000351	CcSEcCtD
Galantamine—Dermatitis—Etoposide—lung cancer	3.79e-05	0.00035	CcSEcCtD
Galantamine—Headache—Etoposide—lung cancer	3.77e-05	0.000349	CcSEcCtD
Galantamine—Flatulence—Doxorubicin—lung cancer	3.77e-05	0.000348	CcSEcCtD
Galantamine—Chest pain—Methotrexate—lung cancer	3.76e-05	0.000348	CcSEcCtD
Galantamine—Arthralgia—Methotrexate—lung cancer	3.76e-05	0.000348	CcSEcCtD
Galantamine—Myalgia—Methotrexate—lung cancer	3.76e-05	0.000348	CcSEcCtD
Galantamine—Tension—Doxorubicin—lung cancer	3.76e-05	0.000347	CcSEcCtD
Galantamine—Vomiting—Paclitaxel—lung cancer	3.75e-05	0.000347	CcSEcCtD
Galantamine—Dysgeusia—Doxorubicin—lung cancer	3.75e-05	0.000346	CcSEcCtD
Galantamine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	3.74e-05	0.000345	CcSEcCtD
Galantamine—Rash—Paclitaxel—lung cancer	3.72e-05	0.000344	CcSEcCtD
Galantamine—Dermatitis—Paclitaxel—lung cancer	3.72e-05	0.000344	CcSEcCtD
Galantamine—Discomfort—Methotrexate—lung cancer	3.72e-05	0.000343	CcSEcCtD
Galantamine—Nervousness—Doxorubicin—lung cancer	3.72e-05	0.000343	CcSEcCtD
Galantamine—Back pain—Doxorubicin—lung cancer	3.7e-05	0.000342	CcSEcCtD
Galantamine—Headache—Paclitaxel—lung cancer	3.7e-05	0.000342	CcSEcCtD
Galantamine—Hypersensitivity—Docetaxel—lung cancer	3.69e-05	0.000341	CcSEcCtD
Galantamine—Muscle spasms—Doxorubicin—lung cancer	3.68e-05	0.00034	CcSEcCtD
Galantamine—Confusional state—Methotrexate—lung cancer	3.64e-05	0.000336	CcSEcCtD
Galantamine—Vision blurred—Doxorubicin—lung cancer	3.61e-05	0.000333	CcSEcCtD
Galantamine—Asthenia—Docetaxel—lung cancer	3.59e-05	0.000332	CcSEcCtD
Galantamine—Nausea—Etoposide—lung cancer	3.58e-05	0.00033	CcSEcCtD
Galantamine—Ill-defined disorder—Doxorubicin—lung cancer	3.55e-05	0.000328	CcSEcCtD
Galantamine—Nervous system disorder—Methotrexate—lung cancer	3.54e-05	0.000327	CcSEcCtD
Galantamine—Anaemia—Doxorubicin—lung cancer	3.54e-05	0.000327	CcSEcCtD
Galantamine—Thrombocytopenia—Methotrexate—lung cancer	3.53e-05	0.000326	CcSEcCtD
Galantamine—Agitation—Doxorubicin—lung cancer	3.52e-05	0.000325	CcSEcCtD
Galantamine—Nausea—Paclitaxel—lung cancer	3.51e-05	0.000324	CcSEcCtD
Galantamine—Skin disorder—Methotrexate—lung cancer	3.5e-05	0.000324	CcSEcCtD
Galantamine—Hyperhidrosis—Methotrexate—lung cancer	3.49e-05	0.000322	CcSEcCtD
Galantamine—Malaise—Doxorubicin—lung cancer	3.45e-05	0.000319	CcSEcCtD
Galantamine—Vertigo—Doxorubicin—lung cancer	3.44e-05	0.000318	CcSEcCtD
Galantamine—Anorexia—Methotrexate—lung cancer	3.44e-05	0.000318	CcSEcCtD
Galantamine—Syncope—Doxorubicin—lung cancer	3.43e-05	0.000317	CcSEcCtD
Galantamine—Diarrhoea—Docetaxel—lung cancer	3.42e-05	0.000316	CcSEcCtD
Galantamine—Palpitations—Doxorubicin—lung cancer	3.38e-05	0.000312	CcSEcCtD
Galantamine—Hypotension—Methotrexate—lung cancer	3.37e-05	0.000311	CcSEcCtD
Galantamine—Loss of consciousness—Doxorubicin—lung cancer	3.36e-05	0.000311	CcSEcCtD
Galantamine—Cough—Doxorubicin—lung cancer	3.34e-05	0.000309	CcSEcCtD
Galantamine—Convulsion—Doxorubicin—lung cancer	3.32e-05	0.000306	CcSEcCtD
Galantamine—Dizziness—Docetaxel—lung cancer	3.31e-05	0.000306	CcSEcCtD
Galantamine—Hypertension—Doxorubicin—lung cancer	3.3e-05	0.000305	CcSEcCtD
Galantamine—Musculoskeletal discomfort—Methotrexate—lung cancer	3.29e-05	0.000304	CcSEcCtD
Galantamine—Insomnia—Methotrexate—lung cancer	3.26e-05	0.000301	CcSEcCtD
Galantamine—Myalgia—Doxorubicin—lung cancer	3.26e-05	0.000301	CcSEcCtD
Galantamine—Chest pain—Doxorubicin—lung cancer	3.26e-05	0.000301	CcSEcCtD
Galantamine—Arthralgia—Doxorubicin—lung cancer	3.26e-05	0.000301	CcSEcCtD
Galantamine—Anxiety—Doxorubicin—lung cancer	3.25e-05	0.0003	CcSEcCtD
Galantamine—Paraesthesia—Methotrexate—lung cancer	3.24e-05	0.000299	CcSEcCtD
Galantamine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	3.24e-05	0.000299	CcSEcCtD
Galantamine—Discomfort—Doxorubicin—lung cancer	3.22e-05	0.000297	CcSEcCtD
Galantamine—Somnolence—Methotrexate—lung cancer	3.21e-05	0.000296	CcSEcCtD
Galantamine—Dry mouth—Doxorubicin—lung cancer	3.19e-05	0.000294	CcSEcCtD
Galantamine—Vomiting—Docetaxel—lung cancer	3.18e-05	0.000294	CcSEcCtD
Galantamine—Dyspepsia—Methotrexate—lung cancer	3.18e-05	0.000293	CcSEcCtD
Galantamine—Rash—Docetaxel—lung cancer	3.16e-05	0.000292	CcSEcCtD
Galantamine—Dermatitis—Docetaxel—lung cancer	3.15e-05	0.000291	CcSEcCtD
Galantamine—Confusional state—Doxorubicin—lung cancer	3.15e-05	0.000291	CcSEcCtD
Galantamine—Decreased appetite—Methotrexate—lung cancer	3.14e-05	0.00029	CcSEcCtD
Galantamine—Headache—Docetaxel—lung cancer	3.14e-05	0.00029	CcSEcCtD
Galantamine—Gastrointestinal disorder—Methotrexate—lung cancer	3.11e-05	0.000288	CcSEcCtD
Galantamine—Fatigue—Methotrexate—lung cancer	3.11e-05	0.000287	CcSEcCtD
Galantamine—Shock—Doxorubicin—lung cancer	3.07e-05	0.000284	CcSEcCtD
Galantamine—Nervous system disorder—Doxorubicin—lung cancer	3.06e-05	0.000283	CcSEcCtD
Galantamine—Thrombocytopenia—Doxorubicin—lung cancer	3.06e-05	0.000283	CcSEcCtD
Galantamine—Tachycardia—Doxorubicin—lung cancer	3.05e-05	0.000282	CcSEcCtD
Galantamine—Skin disorder—Doxorubicin—lung cancer	3.03e-05	0.00028	CcSEcCtD
Galantamine—Hyperhidrosis—Doxorubicin—lung cancer	3.02e-05	0.000279	CcSEcCtD
Galantamine—Anorexia—Doxorubicin—lung cancer	2.98e-05	0.000275	CcSEcCtD
Galantamine—Nausea—Docetaxel—lung cancer	2.97e-05	0.000275	CcSEcCtD
Galantamine—Feeling abnormal—Methotrexate—lung cancer	2.97e-05	0.000275	CcSEcCtD
Galantamine—Gastrointestinal pain—Methotrexate—lung cancer	2.95e-05	0.000273	CcSEcCtD
Galantamine—Hypotension—Doxorubicin—lung cancer	2.92e-05	0.00027	CcSEcCtD
Galantamine—Body temperature increased—Methotrexate—lung cancer	2.85e-05	0.000263	CcSEcCtD
Galantamine—Abdominal pain—Methotrexate—lung cancer	2.85e-05	0.000263	CcSEcCtD
Galantamine—Musculoskeletal discomfort—Doxorubicin—lung cancer	2.85e-05	0.000263	CcSEcCtD
Galantamine—Insomnia—Doxorubicin—lung cancer	2.83e-05	0.000261	CcSEcCtD
Galantamine—Paraesthesia—Doxorubicin—lung cancer	2.8e-05	0.000259	CcSEcCtD
Galantamine—Somnolence—Doxorubicin—lung cancer	2.78e-05	0.000257	CcSEcCtD
Galantamine—Dyspepsia—Doxorubicin—lung cancer	2.75e-05	0.000254	CcSEcCtD
Galantamine—Decreased appetite—Doxorubicin—lung cancer	2.72e-05	0.000251	CcSEcCtD
Galantamine—Gastrointestinal disorder—Doxorubicin—lung cancer	2.7e-05	0.000249	CcSEcCtD
Galantamine—Fatigue—Doxorubicin—lung cancer	2.69e-05	0.000249	CcSEcCtD
Galantamine—Constipation—Doxorubicin—lung cancer	2.67e-05	0.000247	CcSEcCtD
Galantamine—Hypersensitivity—Methotrexate—lung cancer	2.66e-05	0.000246	CcSEcCtD
Galantamine—Asthenia—Methotrexate—lung cancer	2.59e-05	0.000239	CcSEcCtD
Galantamine—Feeling abnormal—Doxorubicin—lung cancer	2.57e-05	0.000238	CcSEcCtD
Galantamine—Gastrointestinal pain—Doxorubicin—lung cancer	2.55e-05	0.000236	CcSEcCtD
Galantamine—Abdominal pain—Doxorubicin—lung cancer	2.47e-05	0.000228	CcSEcCtD
Galantamine—Body temperature increased—Doxorubicin—lung cancer	2.47e-05	0.000228	CcSEcCtD
Galantamine—Diarrhoea—Methotrexate—lung cancer	2.47e-05	0.000228	CcSEcCtD
Galantamine—Dizziness—Methotrexate—lung cancer	2.39e-05	0.00022	CcSEcCtD
Galantamine—Hypersensitivity—Doxorubicin—lung cancer	2.3e-05	0.000213	CcSEcCtD
Galantamine—Vomiting—Methotrexate—lung cancer	2.29e-05	0.000212	CcSEcCtD
Galantamine—Rash—Methotrexate—lung cancer	2.27e-05	0.00021	CcSEcCtD
Galantamine—Dermatitis—Methotrexate—lung cancer	2.27e-05	0.00021	CcSEcCtD
Galantamine—Headache—Methotrexate—lung cancer	2.26e-05	0.000209	CcSEcCtD
Galantamine—Asthenia—Doxorubicin—lung cancer	2.24e-05	0.000207	CcSEcCtD
Galantamine—Nausea—Methotrexate—lung cancer	2.14e-05	0.000198	CcSEcCtD
Galantamine—Diarrhoea—Doxorubicin—lung cancer	2.14e-05	0.000197	CcSEcCtD
Galantamine—Dizziness—Doxorubicin—lung cancer	2.07e-05	0.000191	CcSEcCtD
Galantamine—Vomiting—Doxorubicin—lung cancer	1.99e-05	0.000183	CcSEcCtD
Galantamine—Rash—Doxorubicin—lung cancer	1.97e-05	0.000182	CcSEcCtD
Galantamine—Dermatitis—Doxorubicin—lung cancer	1.97e-05	0.000182	CcSEcCtD
Galantamine—Headache—Doxorubicin—lung cancer	1.96e-05	0.000181	CcSEcCtD
Galantamine—Nausea—Doxorubicin—lung cancer	1.86e-05	0.000171	CcSEcCtD
Galantamine—CHRNA1—Neuronal System—HRAS—lung cancer	5.35e-06	3.72e-05	CbGpPWpGaD
Galantamine—BCHE—Phospholipid metabolism—PIK3CA—lung cancer	5.33e-06	3.7e-05	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—EGFR—lung cancer	5.31e-06	3.69e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	5.26e-06	3.65e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—RRM1—lung cancer	5.25e-06	3.65e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—GSTA3—lung cancer	5.25e-06	3.65e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—GSTA2—lung cancer	5.24e-06	3.64e-05	CbGpPWpGaD
Galantamine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—lung cancer	5.15e-06	3.58e-05	CbGpPWpGaD
Galantamine—BCHE—Neuronal System—MDM2—lung cancer	5.12e-06	3.55e-05	CbGpPWpGaD
Galantamine—CYP3A4—Biological oxidations—CYP2E1—lung cancer	5.11e-06	3.55e-05	CbGpPWpGaD
Galantamine—BCHE—Neuronal System—RAF1—lung cancer	5.1e-06	3.54e-05	CbGpPWpGaD
Galantamine—CHRNA2—Neuronal System—HRAS—lung cancer	5.09e-06	3.54e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—GSTA1—lung cancer	5.06e-06	3.51e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metapathway biotransformation—CYP2E1—lung cancer	5.04e-06	3.5e-05	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—KRAS—lung cancer	5.01e-06	3.48e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—ABCC3—lung cancer	5e-06	3.47e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—COL4A3BP—lung cancer	4.94e-06	3.43e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—AZIN2—lung cancer	4.94e-06	3.43e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—B4GALT5—lung cancer	4.93e-06	3.43e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—AKR1C1—lung cancer	4.84e-06	3.36e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—GSTA4—lung cancer	4.8e-06	3.33e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—UGT1A1—lung cancer	4.7e-06	3.27e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	4.69e-06	3.26e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—GSTA2—lung cancer	4.68e-06	3.25e-05	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	4.61e-06	3.2e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—GNG11—lung cancer	4.53e-06	3.15e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—GSTA1—lung cancer	4.51e-06	3.13e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—APOA1—lung cancer	4.51e-06	3.13e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—ABCC3—lung cancer	4.46e-06	3.1e-05	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	4.46e-06	3.1e-05	CbGpPWpGaD
Galantamine—CHRNA4—Neuronal System—HRAS—lung cancer	4.41e-06	3.07e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—AKR1C1—lung cancer	4.32e-06	3e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—ALDOA—lung cancer	4.32e-06	3e-05	CbGpPWpGaD
Galantamine—CYP3A4—Biological oxidations—GSTP1—lung cancer	4.21e-06	2.93e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ATP5H—lung cancer	4.2e-06	2.92e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—UGT1A1—lung cancer	4.19e-06	2.91e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—NCOA3—lung cancer	4.19e-06	2.91e-05	CbGpPWpGaD
Galantamine—CYP2D6—Biological oxidations—POMC—lung cancer	4.19e-06	2.91e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metapathway biotransformation—GSTP1—lung cancer	4.16e-06	2.89e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	4.12e-06	2.86e-05	CbGpPWpGaD
Galantamine—ACHE—Transmission across Chemical Synapses—HRAS—lung cancer	4.11e-06	2.85e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—ADCY1—lung cancer	4.08e-06	2.83e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—ABCG2—lung cancer	4.08e-06	2.83e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—MMP1—lung cancer	4.07e-06	2.83e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—GNG11—lung cancer	4.04e-06	2.81e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—APOA1—lung cancer	4.02e-06	2.8e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—ENO2—lung cancer	4e-06	2.78e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—HPGDS—lung cancer	4e-06	2.78e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PPP2R1B—lung cancer	3.97e-06	2.76e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—POMC—lung cancer	3.92e-06	2.72e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—GSTT1—lung cancer	3.88e-06	2.69e-05	CbGpPWpGaD
Galantamine—CYP3A4—Biological oxidations—GSTM1—lung cancer	3.87e-06	2.69e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—ALDOA—lung cancer	3.85e-06	2.68e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—GCLC—lung cancer	3.83e-06	2.66e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—CYP2A6—lung cancer	3.83e-06	2.66e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metapathway biotransformation—GSTM1—lung cancer	3.82e-06	2.65e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	3.82e-06	2.65e-05	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	3.76e-06	2.61e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PLBD1—lung cancer	3.74e-06	2.6e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—NCOA3—lung cancer	3.74e-06	2.6e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	3.67e-06	2.55e-05	CbGpPWpGaD
Galantamine—CYP3A4—Biological oxidations—CYP1A1—lung cancer	3.67e-06	2.55e-05	CbGpPWpGaD
Galantamine—BCHE—Transmission across Chemical Synapses—HRAS—lung cancer	3.66e-06	2.55e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—ABCG2—lung cancer	3.64e-06	2.53e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—ADCY1—lung cancer	3.64e-06	2.53e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—MMP1—lung cancer	3.63e-06	2.53e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—ENO1—lung cancer	3.63e-06	2.52e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metapathway biotransformation—CYP1A1—lung cancer	3.62e-06	2.52e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	3.62e-06	2.52e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—ALB—lung cancer	3.57e-06	2.48e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—ENO2—lung cancer	3.57e-06	2.48e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—HPGDS—lung cancer	3.57e-06	2.48e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PPP2R1B—lung cancer	3.54e-06	2.46e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—POMC—lung cancer	3.5e-06	2.43e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—GSTT1—lung cancer	3.46e-06	2.4e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—HSD17B10—lung cancer	3.42e-06	2.38e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—GCLC—lung cancer	3.42e-06	2.38e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—CYP2A6—lung cancer	3.42e-06	2.38e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	3.41e-06	2.37e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—POMC—lung cancer	3.39e-06	2.35e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—CYP2E1—lung cancer	3.26e-06	2.26e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—ENO1—lung cancer	3.24e-06	2.25e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—AZIN2—lung cancer	3.23e-06	2.24e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—COL4A3BP—lung cancer	3.23e-06	2.24e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	3.23e-06	2.24e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—NQO1—lung cancer	3.22e-06	2.24e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—ALB—lung cancer	3.19e-06	2.22e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—CKB—lung cancer	3.18e-06	2.21e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	3.15e-06	2.19e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—MMP2—lung cancer	3.15e-06	2.19e-05	CbGpPWpGaD
Galantamine—ACHE—Neuronal System—HRAS—lung cancer	3.15e-06	2.19e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	3.13e-06	2.17e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—POMC—lung cancer	3.02e-06	2.1e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—CNDP2—lung cancer	2.99e-06	2.08e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—GSTM2—lung cancer	2.99e-06	2.08e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—MTMR3—lung cancer	2.91e-06	2.02e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—CYP2E1—lung cancer	2.91e-06	2.02e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—STK11—lung cancer	2.9e-06	2.02e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—NQO1—lung cancer	2.87e-06	2e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PGAM1—lung cancer	2.84e-06	1.97e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	2.81e-06	1.96e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—MMP2—lung cancer	2.81e-06	1.95e-05	CbGpPWpGaD
Galantamine—BCHE—Neuronal System—HRAS—lung cancer	2.81e-06	1.95e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	2.79e-06	1.94e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ATP5H—lung cancer	2.75e-06	1.91e-05	CbGpPWpGaD
Galantamine—CYP3A4—Biological oxidations—POMC—lung cancer	2.74e-06	1.9e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—PTEN—lung cancer	2.73e-06	1.89e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—CYP2A7—lung cancer	2.71e-06	1.88e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—GSTP1—lung cancer	2.69e-06	1.87e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—SDC4—lung cancer	2.65e-06	1.84e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—CXCL8—lung cancer	2.62e-06	1.82e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—CAT—lung cancer	2.61e-06	1.82e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—EP300—lung cancer	2.6e-06	1.81e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—STK11—lung cancer	2.59e-06	1.8e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—ABCB1—lung cancer	2.54e-06	1.77e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—TYMS—lung cancer	2.5e-06	1.74e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—GSTM1—lung cancer	2.47e-06	1.72e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PLBD1—lung cancer	2.45e-06	1.7e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—PTEN—lung cancer	2.43e-06	1.69e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—GSTA3—lung cancer	2.41e-06	1.68e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—RRM1—lung cancer	2.41e-06	1.68e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—GSTP1—lung cancer	2.4e-06	1.67e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—CYP1A1—lung cancer	2.34e-06	1.63e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—CXCL8—lung cancer	2.34e-06	1.62e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—CAT—lung cancer	2.33e-06	1.62e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—ERCC2—lung cancer	2.32e-06	1.61e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—EP300—lung cancer	2.32e-06	1.61e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—ABCB1—lung cancer	2.27e-06	1.58e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—B4GALT5—lung cancer	2.27e-06	1.58e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—HSD17B10—lung cancer	2.24e-06	1.56e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—TYMS—lung cancer	2.23e-06	1.55e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—GSTA4—lung cancer	2.21e-06	1.53e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—GSTM1—lung cancer	2.2e-06	1.53e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—GSTA2—lung cancer	2.15e-06	1.49e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—CYP1A1—lung cancer	2.09e-06	1.45e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—CKB—lung cancer	2.08e-06	1.45e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—GSTA1—lung cancer	2.07e-06	1.44e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—ERCC2—lung cancer	2.07e-06	1.44e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ABCC3—lung cancer	2.05e-06	1.43e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—APOA1—lung cancer	2.01e-06	1.4e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—AKR1C1—lung cancer	1.99e-06	1.38e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—CNDP2—lung cancer	1.96e-06	1.36e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—GSTM2—lung cancer	1.96e-06	1.36e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—UGT1A1—lung cancer	1.93e-06	1.34e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.92e-06	1.34e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—MTMR3—lung cancer	1.9e-06	1.32e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—GNG11—lung cancer	1.86e-06	1.29e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PGAM1—lung cancer	1.85e-06	1.29e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PIK3CG—lung cancer	1.83e-06	1.27e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—APOA1—lung cancer	1.79e-06	1.25e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ALDOA—lung cancer	1.77e-06	1.23e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—CYP2A7—lung cancer	1.77e-06	1.23e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—POMC—lung cancer	1.75e-06	1.21e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—SDC4—lung cancer	1.73e-06	1.2e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—NCOA3—lung cancer	1.72e-06	1.19e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.72e-06	1.19e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—CREBBP—lung cancer	1.7e-06	1.18e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ADCY1—lung cancer	1.67e-06	1.16e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ABCG2—lung cancer	1.67e-06	1.16e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—HPGDS—lung cancer	1.64e-06	1.14e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ENO2—lung cancer	1.64e-06	1.14e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PIK3CG—lung cancer	1.64e-06	1.14e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PPP2R1B—lung cancer	1.63e-06	1.13e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PIK3CD—lung cancer	1.61e-06	1.12e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—ALB—lung cancer	1.59e-06	1.11e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—GSTT1—lung cancer	1.59e-06	1.11e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—RRM1—lung cancer	1.58e-06	1.1e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—GSTA3—lung cancer	1.58e-06	1.1e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—CYP2A6—lung cancer	1.57e-06	1.09e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—GCLC—lung cancer	1.57e-06	1.09e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—POMC—lung cancer	1.56e-06	1.08e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—CREBBP—lung cancer	1.52e-06	1.05e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ENO1—lung cancer	1.49e-06	1.04e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—B4GALT5—lung cancer	1.48e-06	1.03e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—GSTA4—lung cancer	1.44e-06	1e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PIK3CD—lung cancer	1.44e-06	9.99e-06	CbGpPWpGaD
Galantamine—BCHE—Metabolism—ALB—lung cancer	1.42e-06	9.86e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—GSTA2—lung cancer	1.41e-06	9.77e-06	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PIK3CB—lung cancer	1.4e-06	9.76e-06	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PTGS2—lung cancer	1.39e-06	9.67e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—GSTA1—lung cancer	1.36e-06	9.42e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ABCC3—lung cancer	1.34e-06	9.32e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—CYP2E1—lung cancer	1.34e-06	9.29e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—NQO1—lung cancer	1.32e-06	9.18e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—AKR1C1—lung cancer	1.3e-06	9.02e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—UGT1A1—lung cancer	1.26e-06	8.76e-06	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PIK3CB—lung cancer	1.25e-06	8.71e-06	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PTGS2—lung cancer	1.24e-06	8.63e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—GNG11—lung cancer	1.22e-06	8.45e-06	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PTEN—lung cancer	1.21e-06	8.44e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—STK11—lung cancer	1.19e-06	8.28e-06	CbGpPWpGaD
Galantamine—ACHE—Metabolism—EP300—lung cancer	1.16e-06	8.05e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ALDOA—lung cancer	1.16e-06	8.04e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—NCOA3—lung cancer	1.12e-06	7.81e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—GSTP1—lung cancer	1.1e-06	7.66e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ABCG2—lung cancer	1.09e-06	7.6e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ADCY1—lung cancer	1.09e-06	7.6e-06	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PTEN—lung cancer	1.08e-06	7.53e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—CAT—lung cancer	1.07e-06	7.45e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—HPGDS—lung cancer	1.07e-06	7.45e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ENO2—lung cancer	1.07e-06	7.45e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PPP2R1B—lung cancer	1.07e-06	7.4e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ABCB1—lung cancer	1.04e-06	7.25e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—GSTT1—lung cancer	1.04e-06	7.22e-06	CbGpPWpGaD
Galantamine—BCHE—Metabolism—EP300—lung cancer	1.03e-06	7.18e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—GCLC—lung cancer	1.03e-06	7.14e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—CYP2A6—lung cancer	1.03e-06	7.14e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—TYMS—lung cancer	1.02e-06	7.12e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—GSTM1—lung cancer	1.01e-06	7.04e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ENO1—lung cancer	9.74e-07	6.77e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—CYP1A1—lung cancer	9.6e-07	6.67e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ERCC2—lung cancer	9.52e-07	6.62e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—CYP2E1—lung cancer	8.74e-07	6.07e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—NQO1—lung cancer	8.64e-07	6e-06	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PIK3CA—lung cancer	8.56e-07	5.95e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—APOA1—lung cancer	8.24e-07	5.72e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—STK11—lung cancer	7.79e-07	5.41e-06	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PIK3CA—lung cancer	7.64e-07	5.31e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PIK3CG—lung cancer	7.52e-07	5.23e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—GSTP1—lung cancer	7.21e-07	5.01e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—POMC—lung cancer	7.16e-07	4.97e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—CAT—lung cancer	7.01e-07	4.87e-06	CbGpPWpGaD
Galantamine—ACHE—Metabolism—AKT1—lung cancer	7e-07	4.86e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—CREBBP—lung cancer	6.97e-07	4.85e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ABCB1—lung cancer	6.82e-07	4.74e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—TYMS—lung cancer	6.7e-07	4.66e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—GSTM1—lung cancer	6.62e-07	4.6e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PIK3CD—lung cancer	6.61e-07	4.59e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ALB—lung cancer	6.53e-07	4.54e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—CYP1A1—lung cancer	6.28e-07	4.36e-06	CbGpPWpGaD
Galantamine—BCHE—Metabolism—AKT1—lung cancer	6.24e-07	4.34e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ERCC2—lung cancer	6.23e-07	4.33e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PIK3CB—lung cancer	5.76e-07	4e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PTGS2—lung cancer	5.71e-07	3.97e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—APOA1—lung cancer	5.39e-07	3.74e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PTEN—lung cancer	4.98e-07	3.46e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PIK3CG—lung cancer	4.92e-07	3.42e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—EP300—lung cancer	4.75e-07	3.3e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—POMC—lung cancer	4.68e-07	3.25e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—CREBBP—lung cancer	4.56e-07	3.17e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PIK3CD—lung cancer	4.32e-07	3e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ALB—lung cancer	4.27e-07	2.97e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PIK3CB—lung cancer	3.77e-07	2.62e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PTGS2—lung cancer	3.73e-07	2.59e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PIK3CA—lung cancer	3.51e-07	2.44e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PTEN—lung cancer	3.26e-07	2.26e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—EP300—lung cancer	3.1e-07	2.16e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—AKT1—lung cancer	2.87e-07	1.99e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PIK3CA—lung cancer	2.3e-07	1.6e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—AKT1—lung cancer	1.88e-07	1.3e-06	CbGpPWpGaD
